Desk› Healthcare› Gland Pharma Ltd

Gland Pharma Ltd

BSE 543245 GLAND INE068V01023

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals NIFTY 500

Filing rhythm · 60 trading days

39 filings · 13 material · busiest 2026-08-10

What it files

Analyst / Investor Meet7 Newspaper Publication4 Press Release3 Postal Ballot3 AGM / EGM2 General2 Change in Directorate2 Resignation2

Filings

39 in the window

25 August 2026

AGM / EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

48th AGM Outcome

AGM/EGM / AGM View filing →
17 August 2026

Concall Transcript

Earnings Call Transcript

Q1FY27 Earnings Call Transcript

Company Update / Earnings Call Transcript View filing →
14 August 2026

Change in Management

Change in Management

Appointment of Chief Executive Officer of the Company

Company Update / Change in Management View filing →
11 August 2026

Newspaper Publication

Newspaper Publication

Newspaper Publication on Q1FY27 Financial Results

Company Update / Newspaper Publication View filing →
10 August 2026

Results

Unaudited Financial Results For The Quarter Ended June 30, 2026

Unaudited Financial results for the quarter ended June 30, 2026

Result / Financial Results View filing →
10 August 2026

Board Outcome

Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2026

Outcome of Board Meeting

Board Meeting / Outcome of Board Meeting View filing →
10 August 2026

Press Release

Press Release / Media Release

Press release on Q1FY27 Financial Results

Company Update / Press Release / Media Release View filing →
10 August 2026

Investor Presentation

Investor Presentation

Investor Presentation on Q1FY27 Financial Results

Company Update / Investor Presentation View filing →
10 August 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Schedule of Investor Meets

Company Update / Analyst / Investor Meet View filing →
10 August 2026

Analyst / Investor Meet

Analyst / Investor Meet - Outcome

Q1FY27 Earnings Call Audio recording

Company Update / Analyst / Investor Meet View filing →
5 August 2026

Press Release

Press Release / Media Release

Gland Pharma announces strategic collaboration with Neuland Laboratories for sterile API Manufacturing

Company Update / Press Release / Media Release View filing →
31 July 2026

AGM / EGM

Notice Of 48Th AGM

Notice of 48th AGM

AGM/EGM / AGM View filing →
31 July 2026

Annual Report

Reg. 34 (1) Annual Report.

Annual Report for the FY 2025-26

Others / Reg. 34 (1) Annual Report View filing →
31 July 2026

BRSR

Business Responsibility and Sustainability Reporting (BRSR)

BRSR Report for the year ended March 31, 2026

Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
31 July 2026

General

Letter To Shareholders

Letter to Shareholders regarding dispatch of 48th AGM Notice and Annual report for the FY 2025-26

Company Update / General View filing →
30 July 2026

Fundraising

Issue of Securities

Grant of Stock Options under Gland Pharma Employee Stock Option Scheme, 2025

Company Update / Issue of Securities View filing →
30 July 2026

ESOP Allotment

Allotment of ESOP / ESPS

Allotment of Equity Shares under ESOPS

Company Update / Allotment of ESOP / ESPS View filing →
29 July 2026

Press Release

Press Release / Media Release

Gland Pharma receives approval for Suggamadex Injection

Company Update / Press Release / Media Release View filing →
28 July 2026

Newspaper Publication

Newspaper Publication

Copy of News Paper Publication

Company Update / Newspaper Publication View filing →
24 July 2026

Board Meeting

Board Meeting Intimation for Declaration Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026

Gland Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated ....

Board Meeting / Board Meeting View filing →
24 July 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Q1FY27 Earnings Call Intimation

Company Update / Analyst / Investor Meet View filing →
20 July 2026

Postal Ballot

Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

Postal Ballot Outcome

AGM/EGM / Postal Ballot View filing →
20 July 2026

Postal Ballot

Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Scrutinizers Report on the Postal Ballot

AGM/EGM / Postal Ballot View filing →
20 July 2026

Change in Directorate

Change in Directorate

Reappointment of Mr. Vetter and Appointment of Mr. Keller as Independent Directors of the Company

Company Update / Change in Directorate View filing →
16 July 2026

General

Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Intimation of Order passed by the Customs Authority

Company Update / General View filing →
14 July 2026

SAST

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund

Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
13 July 2026

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2026

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
26 June 2026

Trading Window

Closure of Trading Window

Closure of Trading Window

Insider Trading / SAST / Closure of Trading Window View filing →
22 June 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Schedule of Investor Meet

Company Update / Analyst / Investor Meet View filing →
19 June 2026

Newspaper Publication

Newspaper Publication

Copy of Newspaper Publication

Company Update / Newspaper Publication View filing →
18 June 2026

Postal Ballot

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Notice of the Postal Ballot

AGM/EGM / Postal Ballot View filing →
17 June 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Schedule of Investor Meet

Company Update / Analyst / Investor Meet View filing →
16 June 2026

Resignation

Resignation of Director

Please find enclosed the announcement

Company Update / Resignation of Director View filing →
16 June 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Schedule of Investor Meet Intimation

Company Update / Analyst / Investor Meet View filing →
15 June 2026

Outcome

Board Meeting Outcome for Outcome Of Board Meeting - 15.06.2026

Outcome of Board Meeting - 15.06.2026

Others / Outcome without intimation View filing →
15 June 2026

Change in Directorate

Change in Directorate

Changes among Board of Directors of the Company

Company Update / Change in Directorate View filing →
15 June 2026

Resignation

Resignation of Director

Resignation of Mr. C.S.N. Murthy, Independent Director of the Company with effect from the close of business hours on June 15, 2026

Company Update / Resignation of Director View filing →
10 June 2026

Newspaper Publication

Newspaper Publication

Copy of Newspaper Publication

Company Update / Newspaper Publication View filing →
4 June 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Schedule of Investor Meets on June 09 to June 11, 2026

Company Update / Analyst / Investor Meet View filing →